Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GB268 in Advanced Breast Cancer
NCT07738341Phase 2Not yet recruiting
- Sponsor
- Eddingpharm
- Start
- Aug 2026
- Primary completion
- Aug 2029
01
Overview
A Phase 2 trial of GB268 in breast cancer, sponsored by Eddingpharm. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
GB268
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07738341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07738341.